Meningococcal ACWYX conjugate vaccine in 2–29 year-olds in Mali and Gambia

BACKGROUND: An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. This trial assessed the safety and immunogenicity of NmCV-5, a pentavalent ACWYX vaccine. METHODS: We conducted a phase 3, non-inferiority trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidara, Fadima Cheick, Umesi, Ama, Sow, Samba O., Ochoge, Magnus, Diallo, Fatoumata, Imam, Abdulazeez, Traore, Youssouf, Affleck, Lucy, Doumbia, Moussa F., Daffeh, Bubacarr, Kodio, Mamoudou, Wariri, Oghenebrume, Traoré, Awa, Jallow, Edrissa, Kampmann, Beate, Kapse, Dhananjay, Kulkarni, Prasad S., Mallya, Asha, Goel, Sunil, Sharma, Pankaj, Sarma, Annamraju D., Avalaskar, Nikhil, Marc LaForce, F., Alderson, Mark R., Naficy, Abdi, Lamola, Steve, Tang, Yuxiao, Martellet, Lionel, Hosken, Nancy, Simeonidis, Evangelos, Welsch, Jo Anne, Tapia, Milagritos D., Clarke, Ed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627475/
https://www.ncbi.nlm.nih.gov/pubmed/37224196
http://dx.doi.org/10.1056/NEJMoa2214924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627475/
https://www.ncbi.nlm.nih.gov/pubmed/37224196
http://dx.doi.org/10.1056/NEJMoa2214924

Ejemplares similares